Gpax Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Navi Mumbai, Maharashtra, India, established in 2014.
2014 Navi Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Gpax Pharmaceuticals Private Limited

Gpax Pharmaceuticals Private Limited, a active private limited company, was established on 30 September 2014 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233MH2014PTC258452. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹17.69 Cr.

Formerly known as Celogen Generics Private Limited. It upholds a compliant status. Employing 184 professional, Its leadership includes Anuj Somchand Bhagwanji Shah (Director), Amit Rajan (Director), Vikash Naresh Shah (Director). Past directors included Anuj Somchand Bhagwanji Shah, Kuldeep Ratanchand Chauhan, Amit Rajan. It holds ₹17.38 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Off B-106, Techno City, Pl X-4/1, X-4/2, Ttc Area, Midc, Mahape, Navi Mumbai, Maharashtra, 400701.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233MH2014PTC258452

  • Registration Number

    258452

  • Incorporation Date

    30 September 2014

  • Authorized Capital

    ₹20.00 Cr

  • Paid-Up Capital

    ₹17.69 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 20.00 Cr
  • Paid Up Capital ₹ 17.69 Cr
  • Company Age 11 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 17.38 Cr
  • Revenue Growth **** -16.84%
  • Profit Growth **** 16.70%
  • Ebitda **** 224.99%
  • Net Worth -28.05%
  • Total Assets -16.06%
Company report

Gpax Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gpax Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Gpax Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Anuj Somchand Bhagwanji Shah Director 19 Jan 2024 Current
Amit Rajan Director 02 Jan 2015 Current
Vikash Naresh Shah Director 19 Jan 2024 Current
Bharat Kakubhai Katariya Director 19 Jan 2024 Current
Shailesh Kakulal Kataria Director 19 Jan 2024 Current
Rabi Narayan Nayak Director 30 Sep 2014 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2016 Past
Pramod Abcsdd Director 07 Nov 2014 Past
Pramod Abcsdd Additional Director 29 Sep 2016 Past
Pramod Abcsdd Director 30 Mar 2021 Past
Pramod Abcsdd Additional Director 29 Sep 2016 Past
Pramod Abcsdd Director 01 Sep 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gpax Pharmaceuticals.

Gpax Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.84% decrease. The company also saw a substantial improvement in profitability, with a 16.7% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.05%.

Gpax Pharmaceuticals revenue growth over time
Gpax Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -16.84%
*******
*******
*******
*******
Revenue from Operations
*******
 -15.20%
*******
*******
*******
*******
Total Assets
*******
 -16.06%
*******
*******
*******
*******
Profit or Loss
*******
 16.70%
*******
*******
*******
*******
Net Worth
*******
 -28.05%
*******
*******
*******
*******
EBITDA
*******
 224.99%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gpax Pharmaceuticals?

Unlock access to Gpax Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹173,750,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Nkgsb Co.Op. Bank Ltd. : 8.85 Cr
  • Others : 8.53 Cr
Latest Charge Details
Date Lender Amount Status
31 Mar 2023 Others ₹2.55 Cr Open
27 Jul 2018 Others ₹9.75 M Open
18 Jul 2018 Others ₹2.50 Cr Open
26 Oct 2015 Nkgsb Co.Op. Bank Ltd. ₹8.50 M Open
01 Aug 2015 Others ₹2.50 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Gpax Pharmaceuticals?

Gpax Pharmaceuticals has a workforce of 184 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gpax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gpax Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gpax Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Gpax Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Gpax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.

  • Director Appointment

    The activity Anuj Somchand Bhagwanji Shah was appointed as a Director was appointed as a Director on 19 Jan 2024 & has been associated with this company since 2 years 2 months . was completed.

  • Director Appointment

    The activity Vikash Naresh Shah was appointed as a Director was appointed as a Director on 19 Jan 2024 & has been associated with this company since 2 years 2 months . was completed.

  • Director Appointment

    Progress on Bharat Kakubhai Katariya was appointed as a Director was appointed as a Director on 19 Jan 2024 & has been associated with this company since 2 years 2 months . was documented.

  • Director Appointment

    The activity Shailesh Kakulal Kataria was appointed as a Director was appointed as a Director on 19 Jan 2024 & has been associated with this company since 2 years 2 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gpax Pharmaceuticals Private Limited?

The CIN of Gpax Pharmaceuticals Private Limited is U24233MH2014PTC258452.

Where is Gpax Pharmaceuticals Private Limited headquartered?

Gpax Pharmaceuticals Private Limited is headquartered at Off B-106, Techno City, Pl X-4/1, X-4/2, Ttc Area, Midc, Mahape, Navi Mumbai, Maharashtra, 400701.

When was Gpax Pharmaceuticals Private Limited incorporated?

Gpax Pharmaceuticals Private Limited was incorporated on 30 September 2014.

Who are the current directors of Gpax Pharmaceuticals Private Limited?

The current directors of Gpax Pharmaceuticals Private Limited are

What is the primary industry of Gpax Pharmaceuticals Private Limited?

The primary industry of Gpax Pharmaceuticals Private Limited is Manufacturing.

Is Gpax Pharmaceuticals Private Limited a listed company?

Gpax Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Gpax Pharmaceuticals Private Limited?

The authorized capital of Gpax Pharmaceuticals Private Limited is ₹20.00 Cr, and the paid-up capital is ₹17.69 Cr.

What is the compliance status of Gpax Pharmaceuticals Private Limited?

The compliance status of Gpax Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available